Page 58 - Read Online

Page 14 of 14 Lu et al. Microbiome Res Rep 2024;3:17 https://dx.doi.org/10.20517/mrr.2023.44

112. Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and management of hepatic encephalopathy. Clin Liver Dis 2021;25:393-417.
DOI PubMed
113. Hudson M, Schuchmann M. Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the
evidence. Eur J Gastroenterol Hepatol 2019;31:434-50. DOI PubMed PMC
114. Mullish BH, McDonald JAK, Thursz MR, Marchesi JR. Fecal microbiota transplant from a rational stool donor improves hepatic
encephalopathy: a randomized clinical trial. Hepatology 2017;66:1354-5. DOI PubMed
115. Bajaj JS, Salzman NH, Acharya C, et al. Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1,
randomized, placebo-controlled trial. Hepatology 2019;70:1690-703. DOI PubMed PMC
116. Kaji K, Takaya H, Saikawa S, et al. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut
microbiome diversity. World J Gastroenterol 2017;23:8355-66. DOI PubMed PMC
117. Holecek M. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic
perspectives. Metab Brain Dis 2014;29:9-17. DOI PubMed PMC
118. Mahpour NY, Pioppo-Phelan L, Reja M, Tawadros A, Rustgi VK. Pharmacologic management of hepatic encephalopathy. Clin Liver
Dis 2020;24:231-42. DOI PubMed
119. Hu SH, Feng YY, Yang YX, et al. Amino acids downregulate SIRT4 to detoxify ammonia through the urea cycle. Nat Metab
2023;5:626-41. DOI PubMed
120. Kawaguchi T, Taniguchi E, Sata M. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients
with liver cirrhosis. Nutr Clin Pract 2013;28:580-8. DOI PubMed
121. Jiang Q, Jiang G, Welty TE, Zheng M. Naloxone in the management of hepatic encephalopathy. J Clin Pharm Ther 2010;35:333-41.
DOI PubMed
122. Wu G, Wu D, Lo J, et al. A bioartificial liver support system integrated with a DLM/GelMA-based bioengineered whole liver for
prevention of hepatic encephalopathy via enhanced ammonia reduction. Biomater Sci 2020;8:2814-24. DOI PubMed
123. Badal BD, Bajaj JS. Hepatic encephalopathy: diagnostic tools and management strategies. Med Clin North Am 2023;107:517-31.
DOI PubMed
124. Bloom PP, Tapper EB, Young VB, Lok AS. Microbiome therapeutics for hepatic encephalopathy. J Hepatol 2021;75:1452-64. DOI
PubMed PMC
125. Bourlioux P; the workgroup of the French Academy of Pharmacy. Faecal microbiota transplantation: key points to consider. Ann
Pharm Fr 2015;73:163-8. DOI PubMed